Agoracom Blog Home

Archive for the ‘Red Light Holland’ Category

Psychedelics: From Woodstock to Walgreens SPONSOR: Red Light Holland $TRIP.ca $SHRM.ca $RVV.ca $MMED $PLNT.ca $HALO.ca $PSYC.ca

Posted by AGORACOM-Eric at 9:34 AM on Friday, January 22nd, 2021

SPONSOR: Red Light Holland (CSE: TRIP) is engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands. Learn more.

https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

Psychedelic experience is only a glimpse of genuine mystical insight, but a glimpse which can be matured and deepened by the various ways of meditation in which drugs are no longer necessary or useful. If you get the message, hang up the phone. For psychedelic drugs are simply instruments, like microscopes, telescopes, and telephones. The biologist does not sit with eye permanently glued to the microscope, he goes away and works on what he has seen…

– Alan Watts

What Are Psychedelics?

The term “psychedelic” was first used by psychiatrist Humphry Osmond in 1956 during a discussion with Aldous Huxley, the famous author and pioneer of psychedelic consumption. The etymology of the word is derived from the Greek meaning “mind-manifesting”. A more robust definition of the word was developed by Grinspoon and Bakalar:

“a psychedelic drug is one which, without causing physical addiction, craving, major physiological disturbances, delirium, disorientation, or amnesia, more or less reliably produces thought, mood, and perceptual changes otherwise rarely experienced except in dreams, contemplative and religious exaltation, flashes of vivid involuntary memory and acute psychoses.”

– Grinspoon and Bakalar (Multidisciplinary Association for Psychedelic Studies)

Notice that this definition excludes drugs like heroin, methamphetamine, cocaine, and THC, all of which can produce psychedelic effects but are not their primary effect.

2D structural formula and 3D models of Lysergic acid diethylamide (LSD), also known as “acid”.

History of Psychedelic Use

Sacred Ceremonies

Psychedelics have been regarded as sacred plants since the dawn of civilization, with the earliest known consumption of plants containing psychedelic agents occurring in 5000 BCE in Southeastern Algeria . The use of psychedelics to conjure religious experiences was universal amongst humans, as evidenced by depictions of sacred ceremonies centered on these mind-expanding substances found across the globe. The plants which contain these psychedelic agents include mushrooms, cacti, morning glory vines, and even some grasses. Psychedelic ceremonies have shaped many religions and are still used throughout the world.

Examples include:

  • “Soma” found in Sanskrit texts of Hinduism, derived from the Amanita Muscaria mushroom (~1500 BCE)
  • Ergot fungus used in the Eleusinian Mystery Rites of the Greeks, the active ingredient being similar to the synthetic LSD (“acid”) (~2000 BCE)
  • Psylocibin mushrooms used in the town of Villar del Humo in Spain (earliest evidence of psychedelic mushrooms in Europe, ~4000 BCE)
  • Peyote used by the Native Americans, found in the Shumla Caves (~3700 BCE)
  • Modern day usage of psychedelics includes Ayahuasca in the Amazon (active ingredient is DMT), Peyote by the Native Americans in the Western USA, and the global use of Psilocybin.

Earliest depiction of a psychedelic ceremony. Frescos of mushroom-holding shamans were found in caves on the Tassili plateau of Southeastern Algeria.

Sacred ceremonies were (and are) typically led by a Shaman, a respected elder who plays the role of doctor, therapist, and priest. Along with administration of the psychedelic plants, the Shaman provides “non-drug” support to his “patient” to amplify and control the mind-enhancing effects of the compounds. The dreamlike states that the Shaman can invoke brings forth the shadows that lurk in the subconscious into the spotlight of the conscious mind. I have heard frequent users of psychedelics in religious contexts explain the experience as 10 years’ worth of therapy crammed into 4 hours… you are forced to confront your demons and reconcile your angst. These ceremonies are vital to preserving ancient cultures and should be respected as integral parts of religion Now that’s heavy stuff. Let’s move on to something a bit lighter…

Discovery of LSD

Lysergic Acid Diethylamide (“LSD”) is probably the most widely recognized psychedelic substance. Colloquially known as “acid”, LSD was first synthesized in 1938 at the Sandoz research labs in Basel, Switzerland, by Dr. Albert Hofmann. While conducting research into ergot, a fungus that grows on grains and was the cause of mass poisoning in the middle ages (“Saint Anthony’s fire”), Dr. Hofmann realized that the panic-inducing effects of ergot consumption could be attributed to specific alkaloids present in the plant. The basic group of the primary alkaloid (ergobasine) was discovered to be lysergic acid, and several modifications were made to produce LSD as it is known today (“LSD-25”, the 25th modification to the lysergic acid base). The first clinical applications of LSD-25 were tested on controlling blood flow loss in the uterus, but it was quickly determined that the synthetic LSD was not as effective as the naturally occurring substance in ergot. Dr. Hofmann abandoned his research until he accidentally ingested a microscopic amount of LSD via absorption through his skin. According to popular lore, Dr. Hofmann then took an interesting bike ride home during which he was not completely sure whether he was actually moving… upon examination by a medical doctor it was determined that Dr. Hofmann experiencing the full-blown effects of the first acid trip, characterized by pleasant visual distortions and intensely bright colors.

Psychedelics in the Clinic

The LSD-25 compound was tested by other researchers at Sandoz for its potential medicinal benefits. Marketed under the name “Delysid”, Sandoz’s LSD-25 was approved for psychiatric use and disseminated to psychiatrists worldwide. Predicated on the large-scale manufacturing capabilities in the post-WWII 20th century, and the emerging field of psychiatric research and treatment, interest in LSD-25 skyrocketed and hit the public consciousnesses.

Much of the early research into using LSD-25 as a catalyst for inducing changes in brain states was conducted by the CIA in a project known as “MK-ULTRA”. The CIA speculated that LSD could be used as a “truth drug” to assist in interrogations, and in 1953 the agency was given formal approval to test a wide range of psychedelic substances as possible interrogation “enhancers” (LSD being the prime candidate). The MK-ULTRA story is fascinating, fraught with corruption and mysterious deaths, yet the conclusion of the program was uninspiring: LSD-25 is a very poor truth serum and the effects were largely unpredictable between recipients.

Meanwhile, psychiatrists were developing two new models of psychedelic-assisted therapy: psychedelic therapy and psycholytic therapy. Both paradigms involved the use of LSD in treatment, but psycholytic therapy was much a softer approach that involves substantially lesser amounts of LSD than psychedelic therapy, with the goal of bringing about gradual change in personality over the course of months. The underlying theory of psycholytic therapy was based upon Freudian psychoanalysis, with the idea that LSD served as a priming agent by inhibiting the portion of the brain responsible for the ego-identity. LSD was intended to break down the ego and render the patient in a naïve, infantile state of feeling, often associated with derealization and mystic experience. Contrastingly, psychedelic therapy was an attempt to wage total war on the brain using extremely high amounts of LSD dosed in a single session, with the goal of bringing about a symptomatic change in behavior (poorly defined). The original theory was that extremely high doses of LSD could shock alcoholic patients and scare them away from drinking permanently by giving them a horrific experience… but to the clinicians’ surprise the patients experienced very pleasant effects. Emphasis of psychedelic therapy switched to creating a mystical type of experience to re-wire the patient’s brain in a way directed by the psychiatrist or therapist.

“Many people remember vaguely that LSD and other psychedelic drugs were once used experimentally in psychiatry, but few realize how much and how long they were used. This was nota quickly rejected and forgotten fad. Between 1950 and the mid-1960s there were more than a thousand clinical papers discussing 40,000 patients, several dozen books, and six international conferences on psychedelic drug therapy. It aroused the interest of many psychiatrists who were in no sense cultural rebels or especially radical in their attitudes.”

– Grinspoon and Bakalar, 1979

Turn On, Tune in, Drop Out

The popularization of LSD as a substrate for religious-like experiences in American culture was pioneered by the likes of Aldous Huxley, Gerald Heard, Timothy Leary, and Richard Alpert (later to be known as Ram Daas). Their collective work chronicled the psychonaut’s journey through time and space, blending Eastern philosophy with Western ideas. These writings were often written like a piece of “gonzo journalism”, the focus being on the author’s own lived experience. These first-person essays galvanized the public’s curiosity into using psychedelics to unlock latent mental bandwidth and enhance the sensory world.

“The really important facts were that spatial relationships had ceased to matter very much and that my mind was perceiving the world in terms of other than spatial categories. At ordinary times the eye concerns itself with such problems as where? — how far? — how situated in relation to what? In the mescaline experience the implied questions to which the eye responds are of another order. Place and distance cease to be of much interest. The mind does its perceiving in terms of intensity of existence, profundity of significance, relationships within a pattern.”

– Aldous Huxley, The Doors of Perception

Back in the day, loose regulations around controlled substances allowed psychiatrists to give people LSD with little oversight in questionable environments, leading to a surge in recreational use beginning in 1962. FDA regulations began to tighten around the same time, and the introduction of the Kefauver-Harris Drug Amendment forced Sandoz to limit the supply of LSD to physicians at the National Institute of Mental Health. Not long after, the 1965 Drug Control Amendment forced Sandoz to stop supplying LSD entirely (it was later deemed a Schedule 1 substance by the FDA, 1970). As the counter-culture movement of the ‘60s took off, illegal manufacturing and distribution of LSD kept the hippy generation satisfied.

State-of-the-Science

Mechanism of Action

The discovery of the psychedelic effects of LSD in 1943 was followed by the detection of serotonin in the brains of mammals (1953) . Comparison of the serotonin structure with that of LSD revealed a striking similarity in the scaffold of the molecules. Could LSD’s mechanism of action in the brain rely on the same neuronal pathways that serotonin signals through? It was quickly discovered that the mind-altering effects of LSD were attributed to an interference in serotonin signaling in the brain (via competition for the 5-HT2 serotonin receptors) . This discovery catapulted research into the role of serotonin in neuroscience.

Similarity in the serotonin and LSD molecular structures

Clinical Research

The clinical research on psychedelics of the 20th century ended with the Controlled Substances Act of 1970. Fortunately, the recent resurgence in interest into the medical benefits of psychedelics has led to the renewal of experimentation in humans.  On March 5, 2019, esketamine (Janssen Pharmaceuticals, a J&J company) became the first approved psychedelic drug by the FDA for the treatment of psychiatric disorders. Delivered as a nasal spray, esketamine is a pure ketamine substance that has been indicated for major depressive disorder (MDD). Some patients report immediate relief from suicidal ideations, although the greater scientific community is not completely convinced due to the small effect size.

Clinicians are also promoting the use of psilocybin (the active ingredient in magic mushrooms) as a means to increase the patient’s receptivity to talk therapy. A quick search of the ClinicalTrials.gov site reveals that there are 53 ongoing human clinical studies on the therapeutic effects of psilocybin for a wide range of diseases, from anorexia to cancer. Leading the way, a Phase 2 study (N=80; NCT03866174) investigating the antidepressive effects of a single-dose psilocybin administration is currently being conducted by the Usona Institute and was recently granted “Breakthrough Designation”. Compass Pathways is also currently conducting a Phase 2b study (N=216, NCT03775200) for the use of psilocybin in treating treatment resistant depression.

The Multidisciplinary Association for Psychedelics Studies (MAPS) recently raised $30M for its MDMA study in the treatment of PTSD . Granted the “Breakthrough Therapy” designation by the FDA. MAPS’ Phase 3 clinical trials are ongoing with expected approval as early as 2022 . There are 90 other trials currently being conducted on MDMA.

SOURCE: https://www.medicalgold.ca/posts/psychedelics-from-woodstock-to-walgreens

Red Light Holland $TRIP.ca Engages Graham Pechenik, Respected Patent and IP Lawyer and Editor-at-Large of Psilocybin Alpha, as Senior Advisor to Advisory Board $SHRM.ca $RVV.ca $MMED $PLNT.ca $HALO.ca $PSYC.ca

Posted by AGORACOM-Eric at 9:09 AM on Thursday, December 31st, 2020
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

 Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland“) is pleased to announce it has engaged Graham Pechenik to serve as a Senior Advisor to its Advisory Board. Graham is a registered patent attorney, with degrees in Biochemistry and Cognitive Neuroscience. Mr Pechenik gained over a decade of experience representing Fortune 500 companies in the agricultural, chemical, pharmaceutical, biotech, and technology industries before founding Calyx Law in 2016, the first intellectual property law boutique to focus on cannabis and psychedelics. Graham is also editor-at-large of Psilocybin Alpha, where he tracks patent filings and writes about patent issues in the psychedelics space. 

“Adding Graham Pechenik, who is a well-respected lawyer who develops IP strategies, protects IP through patent and trademark filings, and uses IP to generate value and growth, coupled with his strong support and advocacy of responsible use of psychedelics, to Red Light Holland’s Advisory Board, as a Senior Advisor, is another magical moment for the Company,” said Todd Shapiro, the Chief Executive Officer and Director of Red Light Holland. “During the last seven months we have compiled an incredible Advisory Board, including our chair Bruce Linton. Graham was, simply put, another desired piece of the puzzle we were searching for to help round out this very important and active team. We are elated to have Graham join Red Light Holland and our visions of providing responsible legal access of psilocybin, through education and information align tremendously.”

“Having experienced firsthand the benefits of psilocybin mushrooms and microdosing, including for issues involving anxiety, alcohol use, and attention, I’m a strong supporter of making these benefits I’ve seen personally (without making medical claims) available to responsible adults everywhere,” said Graham Pechenik, Founder of Calyx Law. “However, even just discussing the use of mushrooms is heavily stigmatized in most places. I look forward to the day when psilocybin mushrooms and truffles are hopefully more legally accessible, and I am thrilled to help Red Light Holland raise awareness of the magic truffle worldwide. I’m honoured and delighted to work toward this vision with such a stellar team.”

In consideration for his services as Senior Advisor, and subject to all applicable laws (including the rules and policies of the Canadian Securities Exchange) (“Applicable Laws“) the Company has granted to Mr. Pechenik 250,000 incentive stock options (the “Options” and each individually, the “Option“). Each Option will entitle the holder thereof to acquire one common share in the capital of Company for a period of three years from the date of issuance, at an exercise price of $0.315 CND. The Options shall be subject to Applicable Laws and the terms and conditions of the Stock Option Plan of the Company.  

About Red Light Holland Corp.

The Company is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer, Chairman, and Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Red Light Holland $TRIP.ca To Make Groundbreaking Investment in St. Vincent and the Grenadines’ Plant-Based Wellness and Psychedelics Industry $SHRM.ca $RVV.ca $MMED $PLNT.ca $HALO.ca $PSYC.ca

Posted by AGORACOM-Eric at 8:54 AM on Wednesday, December 30th, 2020
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

Toronto, Ontario–(Newsfile Corp. – December 30, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), is pleased to announce it has entered into a non-binding letter of intent to acquire 100% of Mera Life Sciences LLC (“Mera“), a company focused on developing a modern medicinal industry in St Vincent and the Grenadines, with their issued Psychedelic Licenses, which includes the following plants and compounds (the “Compounds”): (i) Mushrooms/Truffles – Psilocybin; (ii) Ketamine; (iii) Ayahuasca; (iv) 3,4-Methyl​enedioxy​methamphetamine (MDMA); (v) 5-methoxy-N,N-dimethyltryptamine (5-MEO-DMT); (vi) Dimethyltryptamine (DMT); (vii) Sassafras; (viii) Ibogaine; (ix) Peyote (x) Papaya; (xi) Aloe Vera; (xii) Arrowroot; (xiii) Soursop; (xiv) Ginger; (xv) Moringa; and (xvi) Coconut Oil.

“The acquisition of Mera and its coveted licenses would allow Red Light Holland to perform high quality psychedelic product research and development, cultivate, extract and process, and export not just Psilocybin, but with compounds such as Ayahuasca, MDMA, DMT, Peyote, Ketamine and many other natural based plants as well. We are The People’s Company and we want to work closely with countries wishing to develop plant and fungus-based remedies – including treatment clinics, and we now understand that St. Vincent and the Grenadines shares our vision.” said Todd Shapiro, CEO and Director of Red Light Holland.

As well, the terms of the agreement will permit Red Light Holland to collaborate with Vincentian entities to import any of the above Compounds.

“The opportunity to explore the inner molecular worlds of multiple plant species, including a variety of psychedelics, is an exciting one. This could put Red Light Holland in the position to discover novel clinical applications for a variety of natural psychedelics. By utilizing a lab built for this purpose on the (main) island, along with cutting edge artificial intelligence, something I’m very familiar with, Red Light Holland would be approaching the frontier of natural plant based drug discovery,” said Dr. Joseph Geraci, Scientific Advisor of Red Light Holland and CEO of NetraMark Corp.

“Red Light Holland is focused on establishing itself as a multi country operator with natural plants and natural fungi, from growing to distribution of legal sales to potential clinics. We look forward to the careful due diligence process and hopefully adding Mera and their ground-breaking licenses in SVG, which would instantly strengthen our Scientific and Innovation Division, Scarlette Lillie by expanding our vision for research and development and for providing access to natural psychedelics on all fronts,” added Shapiro.

“The emerging modern plant-based medicinal research industry in the Caribbean is the future, and St. Vincent and the Grenadines is leading on this path” The island’s Minister of Agriculture, Hon. Saboto Caesar pointed out. “St. Vincent and the Grenadines has been able to attract experts interested in exploring the medicinal value of indigenous plants, cannabis and other plants that may thrive in tropical conditions and possess medicinal properties.” re-expressed from News 784.

Further details will be announced once made available.

About Mera Life Sciences LLC

Mera Life Sciences LLC is focused on the research and development, cultivation, extraction, processing and completion, exportation and clinics using natural medicines. Mera holds the ability to work with a number of psychedelic substances as part of the previously announced medicinal feasibility study.

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Red Light Holland $TRIP.ca Looking To Receive Exemption for Controlled Substances from Government of Canada, Engages Wellington Dupont Public Affairs $SHRM.ca $RVV.ca $MMED $PLNT.ca $HALO.ca $PSYC.ca

Posted by AGORACOM-Eric at 8:42 AM on Wednesday, December 23rd, 2020
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

December 23, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company”) is pleased to announce that it has hired Wellington-Dupont Public Affairs (“Wellington-Dupont“) to provide government relations support and lobbying services on behalf of the Company. Wellington-Dupont has approached the Government of Canada in the hopes of initiating first steps for Red Light Holland to receive an exemption for controlled substances use as part of clinical studies, in order to safely analyze the potential positive impacts of psilocybin on mental health.

“We have a big idea. But we need to carefully proceed, in order for it to hopefully come to fruition,” said Red Light Holland CEO and director Todd Shapiro. “This is why we have hired expert lobbying and government relations firm, Wellington Dupont Public Affairs. Through Wellington Dupont, we look forward to engaging the federal government to discuss the usage of natural psilocybin products, and their potential benefits.”

“We are pleased to represent Red Light Holland as they seek an exemption for controlled substances use as part of a clinical study,” said Summer Senter, Consultant Lobbyist at Wellington-Dupont Public Affairs. “Together we are working with another group to build a detailed plan that will lead to potentially ground-breaking and positive change in Canada. We look forward to sharing more news, when appropriate.”

About Wellington Dupont

Wellington Dupont is a North American public affairs firm with strong talent working closely across Canada and the United States. With offices across Canada and the United States, Wellington Dupont’s approach ensures consistent and seamless results throughout all offices while keeping top of mind policy and regulations on both sides of the border.

Wellington Dupont’s team of trusted advisors uses their combined experience in media relations, business, politics, and government to provide sound counsel and strategic advice while helping clients achieve results.

Contact: [email protected]

About Red Light Holland Corp.

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on Red Light Holland:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

VIDEO – Red Light Holland $TRIP.ca $TRUFF Sells Out First 100,000 Grams Of Magic Truffles, Increases 2nd Batch 10X To 1,000,000 Grams $SHRM.ca $RVV.ca $MMED $PLNT.ca $HALO.ca $PSYC.ca

Posted by AGORACOM-JC at 4:42 PM on Tuesday, December 22nd, 2020
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

The dawn of the psychedelics industry could not have come at a more needed time for humanity, as global events have served to exacerbate mental health issues related to anxiety and depression. Investors will need help identifying best of breed psychedelics companies and a review of the Red Light Holland story is all you need to know about where the Company is going.  

Red Light Holland (TRIP:CSE) is a psychedelics company focused on the development of premium “magic” truffles in the Netherlands. More than just lip service the Company already has these two very strong pillars in place:

COMMERCIALIZATION – The Company’s recreational brand of magic truffles are already being sold in the Netherlands through existing Smart Shops, as well as, its e-commerce platform through microdose packs.   To this end, TRIP has already sold its first 100,000 grams of magic truffles months ahead of schedule, and has now increased production by 10X to 1,000,000 grams (not a typo).   

TEAM – In order to help guide the company’s development and operations in the psychedelics space, TRIP has signed former Canopy Growth CEO Bruce Linton as chair of its advisory board and Former Canadian Health Minister, Tony Clement, as Senior Advisor.  Company President Hans Derix is a native of the Netherlands and an expert in the space with over a decade of accomplished experience.

As if that wasn’t enough, TRIP has also produced a virtual reality experience for prospective customers who want to experience the effects of their products before actually trying it.  The AGORACOM thesis of small cap wealth creation this decade is the convergence of emerging technologies – but even we didn’t foresee the explosive intersection of virtual reality and psychedelics!

If you believe in the future of Psychedelics and Psilocybin in particular, then this interview with Todd Shapiro, CEO of Red Light Holland will be a TRIP.  

Red Light Holland $TRIP.ca Commences Growing 1,000,000 Grams of Magic Truffles $SHRM.ca $RVV.ca $MMED $PLNT.ca $HALO.ca $PSYC.ca

Posted by AGORACOM-Eric at 9:25 AM on Tuesday, December 15th, 2020
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

Toronto, Ontario–(Newsfile Corp. – December 15, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland“) is pleased to announce that is has commenced growing its second crop of approximately 1,000,000 (1 Million) grams of magic truffles consisting of three different strains, including Psilocybe Mexicana, Psilocybe Galindoi, and Psilocybe Tampanensis.

“Red Light Holland is ecstatic to announce that we have started to grow our second batch of magic truffles, expected to be 10X the original batch’s size totalling an expected 1,000,000 (1 Million) grams of Magic Truffles. We are proud as a company, in the Psychedelic sector to actually produce product now, as opposed to making mere projections about the future. We believe in providing responsible adult access now, through education and information and we are happy to be moving so quickly and efficiently,” said Todd Shapiro, Chief Executive Officer and Director of Red Light Holland. “We are almost done harvesting our expected first batch, which has been pre-sold, and we are again, excited for this future growth.”

“This is another great day for the Company. We have perfected the harvest process right through to packaging and we are excited to be growing this very large amount of Truffles,” added Hans Derix, President of Red Light Holland (who resides in Horst). “Red Light Holland’s growth operation, including sourcing of truffle’s genetics and working with substrates in a proven and perfect growing environment, including working with the proper equipment to complete the growth process from harvest right through to packaging and distribution is something we are truly proud of.”

Red Light Holland’s growth operation, which is approximately 3,000 square feet custom built, indoor growing, production and distribution facility is in Horst, The Netherlands. The expected batch of 1,000,000 grams of Magic truffles, including Psilocybe Mexicana, Psilocybe Galindoi, and Psilocybe Tampanensis is expected to be available in the Netherlands in mid 2021.

About Red Light Holland Corp.

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on Red Light Holland:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Toronto, Ontario–(Newsfile Corp. – December 15, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland“) is pleased to announce that is has commenced growing its second crop of approximately 1,000,000 (1 Million) grams of magic truffles consisting of three different strains, including Psilocybe Mexicana, Psilocybe Galindoi, and Psilocybe Tampanensis.

“Red Light Holland is ecstatic to announce that we have started to grow our second batch of magic truffles, expected to be 10X the original batch’s size totalling an expected 1,000,000 (1 Million) grams of Magic Truffles. We are proud as a company, in the Psychedelic sector to actually produce product now, as opposed to making mere projections about the future. We believe in providing responsible adult access now, through education and information and we are happy to be moving so quickly and efficiently,” said Todd Shapiro, Chief Executive Officer and Director of Red Light Holland. “We are almost done harvesting our expected first batch, which has been pre-sold, and we are again, excited for this future growth.”

“This is another great day for the Company. We have perfected the harvest process right through to packaging and we are excited to be growing this very large amount of Truffles,” added Hans Derix, President of Red Light Holland (who resides in Horst). “Red Light Holland’s growth operation, including sourcing of truffle’s genetics and working with substrates in a proven and perfect growing environment, including working with the proper equipment to complete the growth process from harvest right through to packaging and distribution is something we are truly proud of.”

Red Light Holland’s growth operation, which is approximately 3,000 square feet custom built, indoor growing, production and distribution facility is in Horst, The Netherlands. The expected batch of 1,000,000 grams of Magic truffles, including Psilocybe Mexicana, Psilocybe Galindoi, and Psilocybe Tampanensis is expected to be available in the Netherlands in mid 2021.

About Red Light Holland Corp.

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on Red Light Holland:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Red Light Holland $TRIP.ca and Disruptive Pharma Announce Intention to Form Joint Venture in Brazil $SHRM.ca $RVV.ca $MMED $PLNT.ca $HALO.ca $PSYC.ca

Posted by AGORACOM-Eric at 8:38 AM on Monday, December 14th, 2020
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

Toronto, Ontario–(Newsfile Corp. – December 14, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland“), and Disruptive Pharma, a Latin American focused pharmaceutical investment company, are pleased to announce they have entered into a non-binding letter of intent for the purposes of creating a joint venture to cultivate, manufacturer, and commercialize magic truffles for the Brazilian market and to explore other potential business opportunities, subject to compliance with all applicable laws and regulations of Brazil, home to more than 200 million people.

Disruptive Pharma is focused on developing innovative solutions for the health and wellness industry and is a principal investor in Mundihealth.com (MundiHealth), a US based company and the owner of MyPharma2GO.com (MyPharma2Go), a large prescribed medicines website distributing to Brazil and Latin America. MundiHealth.com also has exclusive distribution agreements with some of the largest and most well established vitamin and supplement brands in the world.

“Brazil’s market is huge and we are pleased to enter into this LOI with Disruptive Pharma, with the opportunity to leverage their entire portfolio of companies including MyPharma2Go.com, a large Brazilian online pharmaceutical and supplement distributor,” said Todd Shapiro, CEO and Director of Red Light Holland. “We look forward to bringing our knowledge in growing Magic Truffles for the purposes of cultivating, manufacturing, and distributing in Brazil, while we continue to build our Red Light Holland Brand, sell our iMicrodose packs, and expand our e-commerce strategies.”

Red Light Holland’s intention is to leverage Disruptive Pharma’s proven distribution and health technology experience with their proven knowledge in growing magic truffles. The two company’s visions align as both Red Light Holland and Disruptive Pharma believe in providing responsible access to products that have the potential to enhance quality of life, especially for those in need of innovative treatments and those who have not succeeded with traditional medicines. Red Light Holland and Disruptive Pharma will carefully explore the legalities of magic truffles and magic mushroom products in Brazil and further details of the proposed joint venture will be announced once available.

About MyPharma2GO

In Brazil and other LatAm countries, specific legislation permits consumers to import medicines, medical devices, OTCs and health products. Established in 2018 and headquartered in the US, Mundihealth / MyPharma2Go uses this legislation to bring HCP-focused pharmaceuticals and/or B2C supplements towards the region. By contracting MP2Go’s business services, companies can launch products within 30 days following agreement, legally sidestepping a 1-3 year registration process with Health Authorities, anticipating revenue and testing the market without committing high monetary investment. Once the prescription has been generated and the product purchased, MP2Go dispatches it from its FDA-approved warehouse in Florida, Netherlands or Israel via its proprietary courier service. This permits full tracking of the items, which are delivered directly to the consumer in 7-10 business days under full compliance of Health Authorities and Customs. Customer Care is also a priority for the company, covering all aspects of the HCP and patient/consumer journeys aiming recurrence and solid growth for all brands allied to great user experience.

About Red Light Holland Corp.

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on Red Light Holland:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Red Light Holland $TRIP.ca Announces Intention to Acquire Controlling Interest in Psychedelic Insights $SHRM.ca $RVV.ca $MMED $PLNT.ca $HALO.ca $PSYC.ca

Posted by AGORACOM-Eric at 8:57 AM on Wednesday, December 9th, 2020
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland“) is pleased to announce it has entered into a non-binding letter of intent to acquire 51% of Psychedelic Insights in Amsterdam, the Netherlands. Psychedelic Insights currently provides psychedelic assistance to clients from all over the world, who are in need and wanting to try a safe and psychological guided experience. Psychedelic Insights’ dedicated and compassionate facilitators, including a team of psychiatrists, psychologists, therapists and scientists, provide psychological guidance of psychedelic experiences in many different categories including: (i) individuals or small groups (ii) psychedelic palliative care (iii) Re-connecting Veterans and (iv) provides global mental health screening. Psychedelic Insights portfolio also includes unique therapist training and psychedelic assisted leadership coaching.

As part of the expected 51% acquisition, a condition in the agreement will include: an exclusive supply agreement with Red Light Holland’s Truffles, grown from Red Light Holland’s facility in Horst, Netherlands with the intention to be used solely by Psychedelic Insights’ clients.

“I find it so interesting that behind the scenes we’ve been working on this deal for months in the Netherlands, and we just happened to agree to it on the same day Canada granted 17 healthcare professionals to possess and use psilocybin for professional training in psilocybin therapy,” said CEO Todd Shapiro. “Luc Van Poelje, CEO of Psychedelic Insights and his team have a very professional and compassionate business and we are looking forward to potentially helping it grow, because of the capital Red Light Holland can provide. There is a careful due diligence process, but we are very excited at this potential to create another alternative revenue stream as we stay true to our mission of helping people gain access to psilocybin via our Red Light Holland Truffles, responsibly.”

“Our team of psychiatrists, psychologists, therapists and scientists at Psychedelic Insights are all excited to potentially be partnering with Red Light Holland so we can continue to grow our psychedelic assisted service to clients from all over the world, who are in need and wanting to try a safe and psychologically guided experience. Our dedicated and compassionate facilitators are also pleased to potentially use Red Light Holland’s Truffles, exclusively and are pleased at this intention to grow our business so ultimately we can hopefully help more people in need,” added Luc Van Poelje, CEO Psychedelic Insights.

Recently, Red Light Holland announced a non-binding letter of intent with Halo Labs Inc. (“Halo“) for the purposes of creating a joint venture to become a licensed psilocybin manufacturer to supply psilocybin products to licensed service centers in the State of Oregon, and to explore other potential business opportunities in this new regulated market, subject to compliance with all applicable Oregon laws and regulations. The planned acquisition of a majority interest in Psychedelic Insights in The Netherlands keeps in line with the aforementioned theme and future plans of Red Light Holland’s potentially being involved (in multiple countries) in legal psilocybin-assisted initiatives.

In Canada on December 8th, 2020, 17 healthcare professionals were approved by the Canadian Federal Health Minister, Patty Hajdu, to possess and use psilocybin for professional training in psilocybin therapy. The approved healthcare professionals include psychologists, psychiatrists, clinical counselors, social workers, general practitioners, and nurses.

Further details will be announced once made available.

About Psychedelic Insights

Psychedelic Insights provides legal, safe and psychological guidance of magic (psilocybin) truffle experiences based in Amsterdam, The Netherlands.

You can learn more about the company here: https://www.psychedelicinsights.com/

About Red Light Holland Corp.

Red Light Holland is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on Red Light Holland:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]redlighttruffles.com
Website: https://redlighttruffles.com/

Red Light Holland $TRIP.ca Announces Logo Redesign Contest with Russell Peters and Khloë Including $15,000 in Prizes $SHRM.ca $RVV.ca $MMED $PLNT.ca $HALO.ca $PSYC.ca

Posted by AGORACOM-Eric at 9:17 AM on Tuesday, December 8th, 2020
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

Toronto, Ontario–(Newsfile Corp. – December 8, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland“) is pleased to announce the company will be launching a Logo Redesign Contest on December 14th, 2020 at 8:30am, on multiple social media channels. The premise of the Red Light Holland Logo Redesign Contest is to receive input from graphic designers, artists, day dreamers, psychedelic advocates, influencers, brand builders, creative types, even non creative types – essentially anybody and everybody, who would like to contribute to helping build Red Light Holland’s Brand, reflecting those who support our mission of providing access, while being inclusionary and giving back.

Red Light Holland will announce the rules and regulations for the Logo Redesign Contest on December 14th, 2020 at 8:30am where it is expected that participants will be encouraged to go to social media to make their best pitch as to why they should be a part of the Red Light Holland Logo Redesign Committee, joining Chief Creative Officer Russell Peters (4 million Twitter followers, 1.1 million Facebook likes, and 399,000 Instagram followers), and Clothing Brand Ambassador Khloë Terae, (2.4 million followers on Instagram, 2.2 million likes on Facebook, and 647,000 followers on Twitter.) Ultimately, three (3) winners will be chosen before the new year to join the Redesign Committee. Each of the three (3) winners will receive C$5000.00 for their participation in helping Red Light Holland design a new logo, expected to premier early in 2021.

“When Todd pitched this idea to me, my initial response was a rare one because I replied – that’s not a bad idea at all!” said Russell Peters, Red Light Holland Chief Creative Officer. “We are excited to hear, read and see participants’ reasons on Social Media as to why they should be chosen to be a part of this committee with Khloë and me for Red Light Holland’s Logo Redesign Contest. We are elated to put up $15,000 (CND) to the winners for their creative input. This is right up our alley because it’s outside of the box, it connects with people, it’s collaborative and it’s fun.”

“As our Brand grows, I really wanted to have a logo that represented and reflected those who support us and believe in the future of legal access to psychedelics through education and information. Also, because of the current tough economic times, collectively as a company we were thinking of ways to give back, especially during the holiday season,” said Todd Shapiro, Red Light Holland CEO and Director. “Personally the original/retro logo will always be special to me, but creating a committee with the likes of Russell Peters and Khloë is amazing. This creative initiative to add three winners, who no doubt will be extremely talented people, is heart-warming and to be in a position to help provide our three ultimate winners with $5000 (CND) each for their input is music to my ears. Red Light Holland is proud to help reward people for their feedback and hard work. I can’t wait to meet the winners!”

Further details of Red Light Holland’s Logo Redesign Contest, through multiple social media channels with Russell Peters and Khloë, including rules and regulations will be announced once made available. The Logo Redesign Contest will launch on social media on December 14th, 2020 8:30am. Red Light Holland’s 2020 Collection is available now at www.iMicrodose.ca

The Company also announces that it has engaged Octagon Media Corp. (Parent Company of Wall Street Reporter) to provide online marketing, social media, and presentation services for a term of six months. In consideration, the Company has completed cash payments totaling US$125,000, and has granted 750,000 incentive stock options exercisable at a price of C$0.15 and 750,000 options exercisable at a price of C$0.20, each for a period of 12 months.

About Red Light Holland Corp.

Red Light Holland is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on Red Light Holland:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Red Light Holland $TRIP.ca Names Internationally Renowned & Award-Winning Designer Karim Rashid as Head of Design $SHRM.ca $RVV.ca $MMED $PLNT.ca $HALO.ca

Posted by AGORACOM-Eric at 2:27 PM on Thursday, December 3rd, 2020
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

Toronto, Ontario–(Newsfile Corp. – December 3, 2020) –  Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company”) is pleased to name Karim Rashid – Head of Design, for the design and development of the Wisdom Truffle companion. Karim Rashid who has 1.1 million Facebook followers, 210,000 Instagram followers and 29,000 Twitter Followers, has been described by Time Magazine as the “most famous industrial designer in all the Americas”.

Pictured Karim Rashid

If you cannot view this image, please visit:
https://orders.newsfilecorp.com/files/2017/69459_affa6d480485ab83_001full.jpg

“We are thrilled to name world-renowned designer Karim Rashid, Head of Design at Red Light Holland. While focusing on our core business in the Netherlands, our goal is to create alternative revenue streams while building a global brand that oozes every inch of our ethos, which encourages a lifestyle of healthy daily habits including disconnecting from technology and reconnecting with nature and ourselves for mental clarity. Karim, who has worked with global brands such as Giorgio Armani, HUGO BOSS, Veuve Clicquot and Samsung, believes in our vision and together we will bring it to life through the Wisdom Truffle Companion,” said Red Light Holland CEO and Director, Todd Shapiro. “It’s an honour for our company to work with Karim, a beloved, insanely talented and premium designer.”

“When I first met Todd Shapiro I thought he was crazy!” Said Karim Rashid. “But the more I talked to him, the more I knew – to be candid – his team found the perfect person for the job! As Head of Design, I’m elated to design and promote the Wisdom Truffle and help bring it to life. I’m proud to be a part of a creative initiative, that starts a conversation, promotes positivity and provides comfort – it feels like we need that more than ever right now.”

The Wisdom Truffle is expected to be designed by Karim Rashid. The Wisdom Truffle will be a figurine expected to be produced in three different sizes and which can potentially be sold across the world in approximately late 2021. The idea of the Wisdom Truffle is to work through Red Light Holland’s Augmented Reality to encourage people to leave their phone behind and instead recommend one goes for a “walk” or go outside to “exercise” and to “live in the moment”. The Wisdom Truffle’s intention is to highlight an iMicrodose lifestyle which promotes positivity, help put a smile on one’s face and connect people to an enlightened community.

Pictured Wisdom Truffle from Red Light Holland’s VR experience developed by RadixMotion

To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/2017/69459_affa6d480485ab83_002full.jpg

In light of the partnership, Red Light Holland issued Karim Rashid 1,052,631 shares pursuant to the Company’s share issuance plan at $0.095 per share. The shares will be subject to a 4-month hold as per Canadian Securities Exchange rule. In addition, Karim Rashid will be paid a fee of US$50,000 over two phases of product development, as well as a 5% Royalty Fee of net sales.

About Karim Rashid:

Karim Rashid is one of the most prolific and colourful designers of his generation. Over 4,000 designs in production, over 300 awards and working in over 40 countries. His renowned work includes products designed for some of the world’s most prominent brands, such as Christofle, Veuve Clicquot, Alessi, Umbra, Bobble, 3M, Samsung, Asus, Kenzo and Hugo Boss. Karim exhibits art in galleries worldwide and is a winner of the Red Dot Award, Chicago Athenaeum Good Design Award, I. D. Magazine Annual Design Review and IDSA Industrial Design Excellence Award.

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: www.RedLightTruffles.com